Condition
Lupus Nephritis - WHO Class III clinical trials and research
Research outlook What's coming for Lupus: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Lupus Nephritis - WHO Class III clinical trials that are recruiting, in United States. By phase: Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
FT819 in Lupus Nephritis: a targeted cell therapy trial for moderate-to-severe LN
This trial tests whether FT819, a donor-derived CAR T cell therapy, can help people with difficult-to-treat lupus nephritis who have not responded to other medicines.
-
ONT01 for Lupus Nephritis and Systemic Lupus Erythematosus
We will test whether ONT01 is safe and helps adults with lupus nephritis or active SLE when added to standard medicines like mycophenolate.
Related topics
Quick answers
How many Lupus Nephritis - WHO Class III clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.